NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Company Directory Search

Avolynt Inc.

Avolynt Inc.

Avolynt is developing therapeutics for rare and metabolic disease. Avolynt's lead programs target Type 2 diabetes, NASH and Post Bariatric Hypoglycemia.

Company Location

3200 E. Highway 54, Suite 100

Research Triangle Park
NC
27709


P.O. Box 13888

Research Triangle Park
NC
27709
Phone
(919) 659-5677
County
Region

Company Details

Year founded
2015
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Products on market
Remogliflozin, a novel inhibitor of SGLT2, was launched in May 2019.
Products under development